Brief: Bergenbio Presents Pre-Clinical And Clinical Data On Bemcentinib In STK11-positive NSCLC
09/11/2021 13:18
Nov 9 (Reuters) - Bergenbio ASA BGBIO.OL :
* BERGENBIO PRESENTS PRE-CLINICAL AND CLINICAL DATA ON
BEMCENTINIB
IN STK11-POSITIVE NSCLC AT SITC ANNUAL MEETING 2021
Source text for Eikon: ID:nPn1wQlGFa
Further company coverage: BGBIO.OL
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncoinvent ASA
See all newsBrief: Oncoinvent To Raise Up To NOK 140 Million In Private Placement
Brief: Oncoinvent H1 Operating Loss NOK 69 Mln
Brief: Oncoinvent Secures New Patent Expanding Protection For Radspherin
Brief: Oncoinvent's Shares To Be Consolidated In Ratio Of 100:1
Brief: Oncoinvent To Increase Share Capital In Connection With Settlement Of Underwriting Fee